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may not be truly independent but rather an intrinsic part of the senescence pathway described by Krizhanovsky et al. Intriguingly, NK cells, which are attracted by the senescent HSCs, can induce apoptosis of many cell types including HSCs (Radaeva et al., 2006) . It remains to be seen whether this new model is specific to liver fibrosis or whether it represents a more general homeostatic mechanism involved in other wound healing responses. Regardless, this new study clearly demonstrates that the role of cellular senescence extends far beyond cancer prevention.
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Wiemann, S.U., Satyanarayana, A., Tsahuridu, M., Tillmann, H.L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M.A., Manns, M.P., and Rudolph, K.L. (2002) . FASEB J. 16, [935] [936] [937] [938] [939] [940] [941] [942] Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., and Lowe, S.W. (2007) . Nature 445, [656] [657] [658] [659] [660] Mature cytoplasmic messenger RNAs (mRNAs) ready for translation are the products of a complex maturation pathway that starts concomitantly with transcription in the nucleus and includes nuclear pre-mRNA processing, mRNA export through nuclear pore complexes (NPCs), and remodeling of mRNA-ribonucleoprotein (mRNP) complexes in the cytoplasm. Recently, it has become clear that many of the consecutive events in this pathway are tightly interconnected, and the number of factors that influence multiple distinct steps in the mRNP biogenesis pathway is steadily increasing. New work by Bolger et al. (2008) in this issue now explores a fresh twist on the double duty carried out by proteins involved in mRNP biogenesis, in this case the role of the mRNA export factor Gle1 in translation initiation and termination.
Successful export of an mRNA first requires the association of the mRNA with proteins in the nucleus to form an export-competent mRNP. Recognition of this mRNP by the nuclear export receptor Mex67 (TAP/NXF1 in vertebrates) is then needed to facilitate mRNP translocation through NPCs. In addition, several other factors are necessary to ensure efficient mRNA export. Two such essential proteins are the mRNA export factor Gle1 and its partner Dbp5 (for review, see Cole and Scarcelli, 2006) . Dbp5 belongs to the family of DEAD-box-containing RNA helicases, which use the energy of ATP binding and hydrolysis to rearrange RNA structures or to dissociate proteins from RNA. Under steady-state conditions, a pool of both Dbp5 and Gle1 is strategically positioned on the cytoplasmic fibrils of the NPC to remodel mRNPs as soon as they emerge from the NPC channel. Elegant previous studies in the budding yeast Saccharomyces cerevisiae revealed that the low intrinsic, RNAdependent ATPase activity of Dbp5 is greatly stimulated by NPC-associated Gle1 and its soluble cofactor inositol hexakisphosphate (IP 6 ) (Alcazar-Roman et al., 2006; Weirich et al., 2006) . This control of Dbp5 activation by Gle1 (and IP 6 ), which is thought to be locally coupled to the NPC, is critical for efficient mRNA export. It is also involved in mRNP remodeling events such as the dissociation of the RNA-binding protein Nab2 (Tran et al., 2007) and the export receptor Mex67 (Lund and Guthrie, 2005) , which may contribute to the directionality of the mRNA export process.
In addition to the pools of Dbp5 and Gle1 attached to the NPC, both proteins are also found in the cytoplasm. Recent work in budding yeast has revealed a surprising cytoplasmic role for yeast Dbp5 in the termination of translation (Gross et al., 2007) . Translation termination occurs through recognition of a stop codon in the ribosomal A site by the polypeptide release factor eRF1, which together with eRF3 stimulates polypeptidyl-tRNA hydrolysis. In the recent work, Dbp5 was shown to be associated with polysomes and to interact with eRF1/Sup45. It was also required for the recruitment of the release factor eRF3/Sup35 into termination complexes and for efficient read-through of stop codons (Gross et al., 2007) . But how Dbp5 becomes activated to function in translation termination has remained unclear. Bolger et al. (2008) now provide a possible mechanism for Dbp5 activation by demonstrating that both Gle1 and its coactivator IP 6 are necessary for correct termination of translation in budding yeast. These investigators showed that cells that are impaired in Gle1 function (gle1 mutants) exhibit sensitivity to translational inhibitors and synergistic growth defects when combined with mutant polypeptide release factors, as previously observed with dbp5 mutants. Further, gle1 mutants fail to efficiently recruit eRF3/Sup35 to polysomes and promote read-through of stop codons. Because mutations in components of the IP 6 pathway display similar defects, these data point to a role for Gle1 and IP 6 in translation termination via the activation of Dbp5 (Figure 1 ). Given that the requirements for Dbp5 activation in mRNP remodeling after export and translation termination are identical, the question arises whether the failure observed in translational termination is the secondary consequence of earlier defects linked to pre-mRNA export. Several lines of evidence provided by the Bolger et al. study argue against this: (1) the gle1 temperature-sensitive alleles used in this study have only a mild mRNA export defect at their permissive temperature (23°C) but are still sensitive to translational inhibitors and show read-through defects; (2) yeast strains harboring mutations in other factors involved in mRNA export, such as the nucleoporins that are required for Dbp5 and Gle1 docking to the NPC, have severe mRNA export defects but behave normally with respect to translation termination and are insensitive to translation inhibitors; and (3) the stop codon read-through assays used in the study were normalized to a reporter that is equally sensitive to mRNA export defects. Thus, it seems unlikely that the observed requirement for Dbp5, Gle1, and IP 6 in translational termination is an indirect consequence of defective mRNA export. The isolation of gle1 mutant alleles that are specifically impaired in translation termination would further facilitate our understanding of the role of Gle1 in translation termination.
Gle1 Does Double Duty
So how can the observed defects in translation termination be explained? Whereas loading of eRF1/Sup45 into polysomes is normal in yeast strains impaired in Dbp5 or Gle1 function, the recruitment of eRF3/Sup35 is compromised. Moreover, Bolger and colleagues show that Gle1 can directly interact with eRF1/Sup45 and may therefore target Dbp5 to the termination complex. Because the activation of Dbp5 is similar in both the late steps of mRNA export and translation termination, one can assume that Dbp5's RNP remodeling activity triggers an event that promotes eRF3/Sup35 association. The molecular nature of this event and whether it involves RNA unwinding or protein removal is still unclear. Further, it remains to be seen where this RNP remodeling step would occur, presumably either directly on the mRNP close to the termination codon or at the ribosome close to the A site. Remarkably, translation termination can be reconstituted in an in vitro system using purified yeast proteins and short model mRNAs (Pisarev et al., 2007) . Given that the association of release factors with ribosomes is elegantly recapitulated in this in vitro assay, it may offer a great experimental system for studying the contribution of Dbp5, Gle1, and IP 6 to the formation of termination complexes in the future. figure 1. Roles for Gle1 and Dbp5 in mRnP Biogenesis and Translation mRNA export: Upon exit of mRNPs from the nuclear pore complex (NPC), the NPC-associated mRNA export factor Gle1, together with inositol hexakisphosphate (IP 6 ), activates the ATP-dependent RNA helicase Dbp5, resulting in the dissociation of the mRNA export factors Nab2 and Mex67. Dbp5 may arrive at NPCs along with exported mRNPs because it is a shuttling protein that already binds to pre-mRNAs in the nucleus. Translation initiation: eIF4G serves as a scaffold to assemble factors like the eIF3 complex, polyA binding protein (PABP), and eIF4E. Gle1 is required for efficient initiation and interacts with components of the eIF3 complex. Gle1's function in initiation is independent of IP 6 , and the role of Dbp5 remains to be clarified. Translation termination: During termination of translation, Gle1 and Dbp5 promote the incorporation of eRF3/Sup35 into termination complexes. Gle1 directly interacts with eRF1/Sup45 and so may couple Dbp5 activation to terminating ribosomes. Proper recognition of termination codons requires IP 6 , Gle1, and Dbp5, suggesting that Dbp5's ATPase activity is crucial for this process.
The dissociation of 80S ribosomes after termination is promoted by translation initiation factors eIF1, eIF1A, and the eIF3 complex (Pisarev et al., 2007) . In light of this, the second observation by Bolger et al. implicating Gle1 in the initiation step of translation is particularly exciting. Bolger and colleagues link Gle1 with two subunits of the eIF3 complex: Gle1 has genetic interactions with Nip1 (eIF3c) and physically associates with Prt1 (eIF3b). Furthermore, cells lacking functional Gle1 accumulate 80S monosomes, indicative of a defect in translation initiation. Although cells lacking Dbp5 also exhibit accumulation of 80S monosomes (Gross et al., 2007) , there is no evidence yet for a genetic or physical interaction of Dbp5 with the translation initiation machinery. Moreover, the IP 6 pathway was not found to be required for initiation, suggesting that Gle1/IP 6 -dependent activation of Dbp5 is not the mechanism underlying Gle1's role in initiation. Rather, the authors put forward the attractive model that Gle1 could contribute to ribosomal subunit recycling in conjunction with eIF3, thereby helping to couple translation termination to the next round of initiation. Alternatively, Gle1 might influence initiation independently of its role in termination. More biochemical experiments will be required to clarify the role of Gle1, and potentially Dbp5, in translation initiation.
The new roles for Gle1 may have implications for understanding human diseases caused by mutations in human GLE1 (hGLE1). A recent study reported that heritable mutations in hGLE1 are the cause of lethal congenital contracture syndrome type 1 (LCCS1), a fetal motor neuron disease associated with prenatal death. Two related disorders, LCCS2 and LCCS3, have also been analyzed, and those mutations map to factors acting in the phosphatidyl inositol pathway (Nousiainen et al., 2008 , and references therein). The new findings by Bolger et al. implicating Gle1 and IP 6 in mRNA export and translation beg the question of whether these syndromes could be due to defects in translation or mRNA export. Future functional analysis of the inherited mutations in these diseases could provide valuable insights into the molecular defects underlying human pathology caused by mutations in GLE1.
With the discovery that RNA interference (RNAi) occurs in mammalian cells (Elbashir et al., 2001) , it immediately became clear that RNAi is not only a powerful tool for basic research but also may represent a new therapeutic approach against viral infections and cancer. Numerous studies have established the proof of concept that diseases can be targeted by therapeutic RNAi, and several small interfering RNAs (siRNAs) are currently being tested in clinical trials (Grimm and Kay, 2007) . Despite these rapid advances, significant hurdles still need to be overcome for the widespread therapeutic application of siRNAs. Perhaps the greatest challenge is the delivery of effective quantities of siRNAs into the cytoplasm of relevant target cells 
